As insurers prepare to implement a law designed to make health coverage affordable, insurance rates are dramatically increasing.
Many provisions in the Affordable Care Act are designed to protect consumers and lower the cost of insurance. Health insurance companies can’t reject someone for coverage for a medical reason and can’t place lifetime limits on medical coverage. The law also limits how much insurers can charge based on age.
But as insurers prepare to implement a law designed to make health coverage affordable, insurance rates are dramatically increasing. And when the Affordable Care Act really takes effect next year, rates are expected to skyrocket. Florida’s insurance commissioner told the Palm Beach Post that he expects rates in the individual market to climb 30% to 40% next year and in the small-group market to increase by 5% to 20%.
In Florida, 11 insurers filed double-digit rate hikes with the state between May 2012 and June 2013. Several of the state’s largest insurers proposed average rate increases for individual policies of between 10% and nearly 16%, according to rate filings with the state. Florida Blue, for instance, received approval in April to raise premiums on nearly 160,000 individual policies by 14.7%.
Read the full story here: http://bit.ly/1dCSLX4
Source: Florida Trend
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More